| Literature DB >> 34871245 |
Takeshi Okamoto1,2, Hidekazu Suzuki2, Katsuyuki Fukuda1.
Abstract
ABSTRACT: The similarities and differences between acute esophageal necrosis and severe reflux esophagitis have not been elucidated. We compared Los Angeles classification Grade C reflux esophagitis, Grade D reflux esophagitis, and acute esophageal necrosis to consider the similarities and differences between acute esophageal necrosis and severe reflux esophagitis.We retrospectively reviewed records of patients who underwent esophagogastroduodenoscopy at a tertiary referral center from January 2012 to December 2019. Data on patients diagnosed as Grade C reflux, Grade D reflux, or acute esophageal necrosis for the first time were extracted for analysis.A total of 213 patients were enrolled in the study, composed of 130 Grade C reflux, 74 Grade D reflux, and 9 acute esophageal necrosis patients. Compared to Grade C reflux patients, Grade D reflux and acute esophageal necrosis patients were more likely to be transfused (P = .013 and P = .011, respectively), to have duodenal ulcers (P = .025 and P = .049, respectively), and to have psychiatric illnesses (P = .022 and P = .018, respectively). Compared to both Grade C and D reflux, acute esophageal necrosis patients were more likely to present with shock (P = .003 and P < .001, respectively), have type 1 diabetes (P = .030 and P = .004, respectively), and present in winter (P < .001 and P < .001, respectively). Significant step-wise differences (Grade C < Grade D < acute esophageal necrosis) were observed in the need for admission (P < .001 and P = .009), coffee ground emesis (P < .001 and P = .022), and stigmata of hemorrhage on endoscopy (P = .002 and P < .001). Admission (P = .003) and coffee ground emesis (P = .003) independently predicted either Grade D reflux or acute esophageal necrosis over Grade C reflux on multivariate analysis.Shock, type 1 diabetes, and winter may predict acute esophageal necrosis, while the need for admission and coffee ground emesis may predict Grade D reflux or acute esophageal necrosis.Entities:
Mesh:
Year: 2021 PMID: 34871245 PMCID: PMC8568454 DOI: 10.1097/MD.0000000000027672
Source DB: PubMed Journal: Medicine (Baltimore) ISSN: 0025-7974 Impact factor: 1.817
Figure 1Typical endoscopic findings in Los Angeles classification Grade C reflux esophagitis (A), Grade D reflux esophagitis (B), and acute esophageal necrosis (C).
Figure 2Study flow diagram.
Patient characteristics: acute esophageal necrosis.
| Medications before Admission | ||||||||||||||||
| Case | Age | Gender | Presentation | Shock | Transfusion | Medical History | PPI | NSAIDs | Antiplatelet/ Anticoagulants | BZ/Anti-psychotics | Alcohol | Smoking | Thickening of Esophageal Wall (CT) | Hospital Stay (Days) | Hemostatic Procedures | Endoscopies Performed |
| 1 | 83 | F | Vomiting 1 day PTA, followed by hematemesis and shock | + | + | Duodenal ulcer, RE, breast cancer, chronic kidney disease, Zollinger-Ellison syndrome, appendicitis | + | - | - | + | - | - | + | 27 | Duodenum | 4 |
| 2 | 86 | F | Vomiting from 10 days PTA, melena from 4 days PTA | + | + | None | + | - | - | + | - | - | + | 25 | Esophagus, duodenum | 4 |
| 3 | 69 | M | Melena from 5 days PTA, hematemesis from 2 days PTA | - | - | Type 2 DM, duodenal ulcer | - | - | - | - | + | - | + | 5 | - | 1 |
| 4 | 52 | M | Admitted for diabetic ketoacidosis; repeated episodes of vomiting | - | - | Type 1 DM | - | - | - | - | - | + | + | 6 | - | 1 |
| 5 | 74 | F | Melena from 3 days PTA, vomiting 1 day PTA | - | - | Gastric ulcer, alcoholic hepatitis | + | - | - | - | + | - | + | 2 | - | 1 |
| 6 | 39 | M | Coffee ground emesis | + | - | Type 1 DM, chronic kidney disease, depression, irritable bowel syndrome | - | - | - | + | - | + | NA | 7 | - | 2 |
| 7 | 54 | M | Repeated episodes of coffee ground emesis | + | + | Schizophrenia, RE, chronic hepatitis B infection | - | - | - | + | + | - | + | 7 | - | 1 |
| 8 | 82 | F | Frequent vomiting followed by coffee ground emesis | + | + | Breast cancer, paroxysmal atrial fibrillation, angina pectoris, ovarian cancer, RE, appendicitis | - | + | + | - | - | - | + | 2 | - | 1 |
| 9 | 63 | M | Hematemesis from 1 day PTA | - | - | Schizophrenia, type 2 DM | - | - | - | + | + | + | + | 10 | - | 2 |
| Proportion/ Median | 69 | 55% male | 56% | 44% | 33% | 11% | 11% | 56% | 44% | 33% | 100% | 7 | 22% | 1 | ||
BZ = benzodiazepines, CT = computed tomography, DM = diabetes mellitus, NA = not available, NSAIDs = non-steroidal anti-inflammatory drugs, PPI = proton pump inhibitors, PTA = prior to admission, RE = reflux esophagitis.
Initial laboratory data: acute esophageal necrosis.
| Case | Age | Gender | Albumin (g/dL) | BUN (mg/dL) | Creatinine (mg/dL) | White Blood Cells (/μL) | Hemoglobin (g/L) | Platelets (/μL) | CRP (mg/dL) | Glucose (mg/dL) | pH | Lactate (mmol/L) |
| 1 | 83 | F | 3.1 | 52.6 | 2.01 | 19,200 | 10.1 | 360 | 12.5 | 148 | 7.586 | 2.3 |
| 2 | 86 | F | 2.1 | 27.5 | 0.88 | 25,400 | 6.1 | 327 | 6.5 | 96 | 7.574 | 4 |
| 3 | 69 | M | 3.3 | 14.5 | 0.88 | 8400 | 1.7 | 338 | 6.3 | 267 | N/A | NA |
| 4 | 52 | M | 4.6 | 40.5 | 1.55 | 17,800 | 17.0 | 297 | 18.1 | 1039 | 6.937 | 5 |
| 5 | 74 | F | 2.0 | 8.0 | 0.67 | 9300 | 10.0 | 164 | 0.5 | 163 | 7.39 | 4.8 |
| 6 | 39 | M | 3.6 | 51.7 | 2.93 | 26,200 | 11.5 | 28 | 1.7 | 1113 | 7.215 | 4.2 |
| 7 | 54 | M | 1.9 | 60.1 | 2.49 | 54,000 | 5.5 | 254 | 5.0 | 280 | 7.069 | 22 |
| 8 | 82 | F | 0.9 | 28.3 | 0.91 | 9000 | 6.0 | 102 | 15.0 | 15 | 7.501 | 2.8 |
| 9 | 63 | M | 4.8 | 15.8 | 0.76 | 13,100 | 13.7 | 249 | 0.2 | 180 | NA | NA |
| Median | 69 | 3.1 | 28.3 | 0.9 | 17,800 | 10.0 | 254 | 6.3 | 180 | 7.4 | 4.2 |
BUN = blood urea nitrogen, CRP = C-reactive protein, NA = not available.
Patient characteristics.
| RE-C | RE-D | AEN | |||||
| (n = 130) | (n = 74) | (n = 9) | |||||
| Age, median (interquartile range) | 72 | (62–81) | 72 | (60.3–85.8) | 68 | (53–81) | .643 |
| Male, n (%) | 81 | 62.3% | 45 | 60.8% | 5 | 55.6% | .912 |
| Body mass index, median (interquartile range) | 21.8 | (19.1–24.5) | 21.6 | (18.7–24.4) | 20.2 | (19.1–23.4) | .653 |
| Obese, n (%) | 23 | 20.9% | 11 | 17.2% | 2 | 25.0% | .779 |
| Symptoms, n (%) | |||||||
| Admission | 39 | 30.0% | 43 | 58.1% | 9 | 100.0% | <.001∗ |
| Shock | 13 | 10.0% | 12 | 16.2% | 6 | 66.7% | <.001∗ |
| Death | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% | - |
| Transfusion | 12 | 9.2% | 16 | 21.6% | 4 | 44.4% | .002∗ |
| Hematemesis | 12 | 9.2% | 13 | 17.6% | 3 | 33.3% | .044∗ |
| Coffee ground emesis | 15 | 11.5% | 27 | 36.5% | 7 | 77.8% | <.001∗ |
| Vomiting | 26 | 20.0% | 48 | 64.9% | 9 | 100.0% | <.001∗ |
| Melena | 14 | 10.8% | 15 | 20.3% | 4 | 44.4% | .010∗ |
| Abdominal pain | 15 | 11.5% | 12 | 16.2% | 3 | 33.3% | .155 |
| Bright red blood per rectum | 0 | 0.0% | 1 | 1.4% | 0 | 0.0% | .389 |
| Weight loss | 5 | 3.8% | 4 | 5.4% | 0 | 0.0% | .705 |
| Medical/Social History, n (%) | |||||||
| Type 1 diabetes | 0 | 0.0% | 1 | 1.4% | 2 | 22.2% | <.001∗ |
| Type 2 diabetes | 24 | 18.5% | 20 | 27.0% | 2 | 22.2% | .360 |
| Cardiovascular disease | 27 | 20.8% | 15 | 20.3% | 1 | 11.1% | .784 |
| Hypertension | 44 | 33.8% | 28 | 37.8% | 0 | 0.0% | .077 |
| Hyperlipidemia | 14 | 10.8% | 11 | 14.9% | 0 | 0.0% | .365 |
| Psychiatric disorders | 7 | 5.4% | 11 | 14.9% | 3 | 33.3% | .005∗ |
| Chronic kidney disease | 14 | 10.8% | 10 | 13.5% | 2 | 22.2% | .546 |
| Cancer | 14 | 10.8% | 11 | 14.9% | 1 | 11.1% | .688 |
| Systemic sclerosis | 7 | 5.4% | 1 | 1.4% | 0 | 0.0% | .288 |
| Liver cirrhosis | 4 | 3.1% | 6 | 8.1% | 0 | 0.0% | .209 |
| Alcohol use (current or past history, >20 g of ethanol/day) | 47 | 56.6% | 28 | 48.3% | 3 | 37.5% | .084 |
| Smoking (current or past history) | 31 | 39.2% | 23 | 41.1% | 2 | 28.6% | .222 |
| Medications n, (%) | |||||||
| Proton pump inhibitors | 28 | 21.5% | 22 | 29.7% | 5 | 55.6% | .050∗ |
| Histamine 2 blockers | 10 | 7.7% | 4 | 5.4% | 0 | 0.0% | .588 |
| Bisphosphonates | 4 | 3.1% | 4 | 5.4% | 0 | 0.0% | .584 |
| Antithrombotic agents | 23 | 17.7% | 13 | 17.6% | 1 | 11.1% | .879 |
| Benzodiazepines/antipsychotics | 20 | 15.4% | 19 | 25.7% | 4 | 44.4% | .038∗ |
| Non-steroidal anti-inflammatory drugs | 14 | 10.8% | 6 | 8.1% | 0 | 0.0% | .505 |
| Steroids | 6 | 4.6% | 3 | 4.1% | 0 | 0.0% | .798 |
| Diagnosis in winter (December–February) | 32 | 24.6% | 19 | 25.7% | 8 | 88.9% | <.001∗ |
| Other endoscopic findings | |||||||
| Hiatal hernia | 86 | 66.2% | 41 | 55.4% | 4 | 44.4% | .178 |
| Esophageal stricture | 0 | 0.0% | 2 | 2.7% | 0 | 0.0% | .150 |
| Atrophic gastritis | 47 | 36.4% | 22 | 29.7% | 3 | 33.3% | .624 |
| Gastric ulcer | 6 | 4.7% | 10 | 13.5% | 0 | 0.0% | .046∗ |
| Gastric ulcer scar | 6 | 4.7% | 6 | 8.1% | 1 | 11.1% | .501 |
| Post-operative stomach | 14 | 10.9% | 5 | 6.8% | 0 | 0.0% | .388 |
| Duodenitis | 8 | 6.2% | 6 | 8.2% | 1 | 11.1% | .773 |
| Duodenal ulcer (all parts) | 11 | 8.5% | 16 | 21.9% | 3 | 33.3% | .041∗ |
| Duodenal ulcer (1st part) | 9 | 7.0% | 15 | 20.5% | 2 | 22.2% | .012∗ |
| Duodenal ulcer (2nd part) | 6 | 4.7% | 6 | 8.2% | 3 | 33.3% | .005∗ |
| Duodenal ulcer scar | 7 | 5.4% | 12 | 16.4% | 3 | 33.3% | .003∗ |
| Duodenal stricture | 0 | 0.0% | 10 | 13.5% | 1 | 11.1% | <.001∗ |
| Stigmata of hemorrhage | 20 | 15.4% | 25 | 33.8% | 9 | 100.0% | <.001∗ |
| Hemostatic intervention performed | 8 | 6.2% | 4 | 5.4% | 2 | 22.2% | .150 |
AEN = acute esophageal necrosis, RE-C = reflux esophagitis Grade C, RE-D = reflux esophagitis Grade D ∗ denotes statistical significance (P < .05).
One-way analysis of variance used for continuous variables and Pearson Chi–Squared test or Fisher exact test used for categorical variables.
Multiple comparisons and multivariate analysis.
| % Observed | Multiple comparisons: Odds ratios (95% CI) | Multiple comparisons: | Multivariate analysis: | ||||||||
| RE-C | RE-D | AEN | RE-C vs RE-D | RE-D vs AEN | RE-C vs AEN | RE-C vs RE-D | RE-D vs AEN | RE-C vs AEN | RE-C vs RE-D | RE-C vs Re-D+AEN | |
| Symptoms | |||||||||||
| Admission | 30% | 57% | 100% | 3.1 (1.7–5.5) | 1.8 (1.4–2.2) | 3.3 (2.3–4.3) | <.001∗ | .009∗ | <.001∗ | .009∗ | .003∗ |
| Shock | 10% | 16% | 67% | 10.3 (2.3–47.1) | 18.0 (4.0–80.7) | .193 | .003∗ | <.001∗ | |||
| Transfusion | 9% | 22% | 44% | 2.7 (1.2–6.1) | 7.8 (1.9–33.3) | .013∗ | .137 | .011∗ | .936 | .755 | |
| Hematemesis | 9% | 18% | 33% | .081 | .235 | .058 | |||||
| Coffee ground emesis | 12% | 36% | 78% | 4.4 (2.2–9.0) | 6.1 (1.2–31.4) | 26.8 (5.1–141.3) | <.001∗ | .022∗ | <.001∗ | .010∗ | .003∗ |
| Vomiting | 20% | 65% | 100% | 7.4 (3.9–14.0) | 1.5 (1.3–1.8) | 5.0 (3.6–7.0) | <.001∗ | .027∗ | <.001∗ | ||
| Melena | 11% | 20% | 44% | 6.6 (1.6–27.6) | .062 | .116 | .017∗ | ||||
| History | |||||||||||
| Type 1 diabetes mellitus | 0% | 1% | 22% | 20.9 (1.7–259.9) | 6.2 (1.9–20.0) | .363 | .030∗ | .004∗ | |||
| Psychiatric | 5% | 15% | 33% | 3.1 (1.1–8.3) | 8.8 (1.8–42.7) | .022∗ | .173 | .018∗ | .118 | .096 | |
| Medications | |||||||||||
| Proton pump inhibitors | 22% | 30% | 56% | 4.6 (1.1–18.1) | .191 | .120 | .035∗ | ||||
| BZ/antipsychotics | 15% | 26% | 44% | 4.4 (1.1–17.8) | .072 | .209 | .048∗ | ||||
| Diagnosis in winter | 25% | 26% | 89% | 22.2 (2.7–1039.3) | 23.9 (3.0–1091.2) | 0.868 | <0.001∗ | <0.001∗ | |||
| Endoscopic Findings | |||||||||||
| Gastric ulcer | 2% | 14% | 0% | 3.2 (1.1–9.3) | .023∗ | .295 | .664 | .399 | .553 | ||
| Duodenal ulcer | 9% | 22% | 33% | 3.0 (1.3–6.9) | 5.4 (1.2–24.5) | .025∗ | .345 | .049∗ | .151 | .094 | |
| Duodenal ulcer (1st part) | 7% | 20% | 22% | 3.4 (1.4–8.3) | .004∗ | .598 | .153 | ||||
| Duodenal ulcer (2nd part) | 5% | 8% | 33% | 10.2 (2.0–51.3) | .232 | .056 | .013∗ | ||||
| Duodenal ulcer scar | 5% | 16% | 33% | 3.4 (1.3–9.1) | 8.7 (1.8–42.4) | .011∗ | .209 | .019∗ | |||
| Duodenal stricture | 0% | 14% | 11% | 1.2 (1.1–1.3) | <.001∗ | .659 | .065 | ||||
| Stigmata of hemorrhage | 15% | 34% | 100% | 2.8 (1.4–5.5) | 3.0 (2.2–4.1) | 6.5 (4.3–9.7) | .002∗ | <.001∗ | <.001∗ | ||
AEN = acute esophageal necrosis, BZ = benzodiazepines, CI = confidence interval, RE-C = reflux esophagitis Grade C, RE-D = reflux esophagitis Grade D.
Denotes significance (P < .05).
Figure 3Significant differences between Los Angeles classification Grade C reflux esophagitis (RE-C), Grade D reflux esophagitis (RE-D), and acute esophageal necrosis (AEN).